MedTrace Logo

Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia

NCT04964908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1088

Last updated 2024-02-20

No results posted yet for this study

Summary

A Multicenter Retrospective Study to understand the clinical characteristics, treatment pathway and resource utilization for patients with chronic lymphocytic leukemia A retrospective, multi-centre, observational study to describe disease characteristics, treatment patterns, treatment-related outcomes, and resource utilization for Chronic Lymphocytic Leukemia (CLL) patients in multiple international regions

Conditions

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-03
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • Argentina
  • Brazil
  • Chile
  • Colombia
  • Costa Rica
  • Dominican Republic
  • Egypt
  • India
  • Kuwait
  • Malaysia
  • Mexico
  • Panama
  • Saudi Arabia
  • Singapore
  • Taiwan
  • Turkey (Türkiye)
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04964908 on ClinicalTrials.gov